APO Research
Talk to an analyst

APO RESEARCH · REPORT

BCG Tuberculosis (TB) Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global BCG Tuberculosis (TB) Vaccine Industry Growth and Trends Forecast to 2032

20 December 202592 pages

Choose your research edition.

Industry ResearchBCG Tuberculosis (TB) Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal BCG Tuberculosis (TB) Vaccine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal BCG Tuberculosis (TB) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal BCG Tuberculosis (TB) Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal BCG Tuberculosis (TB) Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global BCG Tuberculosis (TB) Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for BCG Tuberculosis (TB) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for BCG Tuberculosis (TB) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for BCG Tuberculosis (TB) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of BCG Tuberculosis (TB) Vaccine include China National Biotec, Sanofi Pasteur, Merck, Serum Institute of India, Japan BCG Lab, Intervax and GSBPL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global BCG Tuberculosis (TB) Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The BCG Tuberculosis (TB) Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global BCG Tuberculosis (TB) Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to BCG Tuberculosis (TB) Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global BCG Tuberculosis (TB) Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

BCG Tuberculosis (TB) Vaccine Market by Company

China National Biotec

Sanofi Pasteur

Merck

Serum Institute of India

Japan BCG Lab

Intervax

GSBPL

BCG Tuberculosis (TB) Vaccine Segment by Type

Immune BCG

Therapy BCG

BCG Tuberculosis (TB) Vaccine Segment by Application

Hospital

Clinic

BCG Tuberculosis (TB) Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BCG Tuberculosis (TB) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of BCG Tuberculosis (TB) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BCG Tuberculosis (TB) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of BCG Tuberculosis (TB) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of BCG Tuberculosis (TB) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Immune BCG Table 2. Major Company of Therapy BCG Table 3. Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (k units) Table 5. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global BCG Tuberculosis (TB) Vaccine Price by Type (2021-2026) & (US$/unit) Table 9. Global BCG Tuberculosis (TB) Vaccine Sales by Type (2027-2032) & (k units) Table 10. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global BCG Tuberculosis (TB) Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global BCG Tuberculosis (TB) Vaccine Price by Type (2027-2032) & (US$/unit) Table 14. North America BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (k units) Table 15. North America BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (k units) Table 17. Europe BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (k units) Table 21. Latin America BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. BCG Tuberculosis (TB) Vaccine Industry Trends Table 25. BCG Tuberculosis (TB) Vaccine Industry Drivers Table 26. BCG Tuberculosis (TB) Vaccine Industry Opportunities and Challenges Table 27. BCG Tuberculosis (TB) Vaccine Industry Restraints Table 28. Global BCG Tuberculosis (TB) Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global BCG Tuberculosis (TB) Vaccine Sales by Company (2021-2026) & (k units) Table 31. Global BCG Tuberculosis (TB) Vaccine Sales Share by Company (2021-2026) Table 32. Global BCG Tuberculosis (TB) Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global BCG Tuberculosis (TB) Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global BCG Tuberculosis (TB) Vaccine Major Company Production Sites and Headquarters Table 35. Global BCG Tuberculosis (TB) Vaccine Company, Product Type & Application Table 36. Global BCG Tuberculosis (TB) Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global BCG Tuberculosis (TB) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global BCG Tuberculosis (TB) Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global BCG Tuberculosis (TB) Vaccine Sales by Region (2021-2026) & (k units) Table 41. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global BCG Tuberculosis (TB) Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global BCG Tuberculosis (TB) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global BCG Tuberculosis (TB) Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global BCG Tuberculosis (TB) Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global BCG Tuberculosis (TB) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global BCG Tuberculosis (TB) Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global BCG Tuberculosis (TB) Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global BCG Tuberculosis (TB) Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global BCG Tuberculosis (TB) Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. North America BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (k units) Table 62. North America BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (k units) Table 64. Europe BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (k units) Table 68. Latin America BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. China National Biotec Company Information Table 72. China National Biotec Business Overview Table 73. China National Biotec BCG Tuberculosis (TB) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. China National Biotec BCG Tuberculosis (TB) Vaccine Product Portfolio Table 75. China National Biotec Recent Development Table 76. Sanofi Pasteur Company Information Table 77. Sanofi Pasteur Business Overview Table 78. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Portfolio Table 80. Sanofi Pasteur Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck BCG Tuberculosis (TB) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Merck BCG Tuberculosis (TB) Vaccine Product Portfolio Table 85. Merck Recent Development Table 86. Serum Institute of India Company Information Table 87. Serum Institute of India Business Overview Table 88. Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Portfolio Table 90. Serum Institute of India Recent Development Table 91. Japan BCG Lab Company Information Table 92. Japan BCG Lab Business Overview Table 93. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Portfolio Table 95. Japan BCG Lab Recent Development Table 96. Intervax Company Information Table 97. Intervax Business Overview Table 98. Intervax BCG Tuberculosis (TB) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Intervax BCG Tuberculosis (TB) Vaccine Product Portfolio Table 100. Intervax Recent Development Table 101. GSBPL Company Information Table 102. GSBPL Business Overview Table 103. GSBPL BCG Tuberculosis (TB) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. GSBPL BCG Tuberculosis (TB) Vaccine Product Portfolio Table 105. GSBPL Recent Development Table 106. North America BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. North America BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (k units) Table 108. North America BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2021-2026) Table 109. North America BCG Tuberculosis (TB) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 110. North America BCG Tuberculosis (TB) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. North America BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America BCG Tuberculosis (TB) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. North America BCG Tuberculosis (TB) Vaccine Market Share by Country (2021-2026) Table 114. North America BCG Tuberculosis (TB) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America BCG Tuberculosis (TB) Vaccine Market Share Forecast by Country (2027-2032) Table 116. Europe BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Europe BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (k units) Table 118. Europe BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2021-2026) Table 119. Europe BCG Tuberculosis (TB) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 120. Europe BCG Tuberculosis (TB) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Europe BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe BCG Tuberculosis (TB) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe BCG Tuberculosis (TB) Vaccine Market Share by Country (2021-2026) Table 124. Europe BCG Tuberculosis (TB) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe BCG Tuberculosis (TB) Vaccine Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (k units) Table 128. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 130. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Share by Country (2021-2026) Table 134. Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Share Forecast by Country (2027-2032) Table 136. Latin America BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Latin America BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (k units) Table 138. Latin America BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2021-2026) Table 139. Latin America BCG Tuberculosis (TB) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 140. Latin America BCG Tuberculosis (TB) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America BCG Tuberculosis (TB) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America BCG Tuberculosis (TB) Vaccine Market Share by Country (2021-2026) Table 144. Latin America BCG Tuberculosis (TB) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America BCG Tuberculosis (TB) Vaccine Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (k units) Table 148. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 150. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Share by Country (2021-2026) Table 154. Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. BCG Tuberculosis (TB) Vaccine Distributors List Table 159. BCG Tuberculosis (TB) Vaccine Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. BCG Tuberculosis (TB) Vaccine Image Figure 2. Global BCG Tuberculosis (TB) Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global BCG Tuberculosis (TB) Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global BCG Tuberculosis (TB) Vaccine Sales (2021-2032) & (k units) Figure 5. Immune BCG Image Figure 6. Global Immune BCG Sales YoY Growth (2021-2032) & (k units) Figure 7. Therapy BCG Image Figure 8. Global Therapy BCG Sales YoY Growth (2021-2032) & (k units) Figure 9. Global BCG Tuberculosis (TB) Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global BCG Tuberculosis (TB) Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 BCG Tuberculosis (TB) Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Global BCG Tuberculosis (TB) Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global BCG Tuberculosis (TB) Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America BCG Tuberculosis (TB) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America BCG Tuberculosis (TB) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America BCG Tuberculosis (TB) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America BCG Tuberculosis (TB) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe BCG Tuberculosis (TB) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe BCG Tuberculosis (TB) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe BCG Tuberculosis (TB) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe BCG Tuberculosis (TB) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America BCG Tuberculosis (TB) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America BCG Tuberculosis (TB) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America BCG Tuberculosis (TB) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America BCG Tuberculosis (TB) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. BCG Tuberculosis (TB) Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. BCG Tuberculosis (TB) Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Immune BCG
  • Therapy BCG
Applications
  • Hospital
  • Clinic
Companies covered
  • China National Biotec
  • Sanofi Pasteur
  • Merck
  • Serum Institute of India
  • Japan BCG Lab
  • Intervax
  • GSBPL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global BCG Tuberculosis (TB) Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global BCG Tuberculosis (TB) Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 BCG Tuberculosis (TB) Vaccine Market by Type
  6. 1.3.1 Immune BCG
  7. 1.3.2 Therapy BCG
  8. 1.4 Global BCG Tuberculosis (TB) Vaccine Market Size by Type
  9. 1.4.1 Global BCG Tuberculosis (TB) Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global BCG Tuberculosis (TB) Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global BCG Tuberculosis (TB) Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America BCG Tuberculosis (TB) Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe BCG Tuberculosis (TB) Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America BCG Tuberculosis (TB) Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 BCG Tuberculosis (TB) Vaccine Industry Trends
  2. 2.2 BCG Tuberculosis (TB) Vaccine Industry Drivers
  3. 2.3 BCG Tuberculosis (TB) Vaccine Industry Opportunities and Challenges
  4. 2.4 BCG Tuberculosis (TB) Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by BCG Tuberculosis (TB) Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by BCG Tuberculosis (TB) Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by BCG Tuberculosis (TB) Vaccine Price (2021-2026)
  4. 3.4 Global BCG Tuberculosis (TB) Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global BCG Tuberculosis (TB) Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global BCG Tuberculosis (TB) Vaccine Company, Product Type & Application
  7. 3.7 Global BCG Tuberculosis (TB) Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global BCG Tuberculosis (TB) Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 BCG Tuberculosis (TB) Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 BCG Tuberculosis (TB) Vaccine Tier 1, Tier 2, and Tier 3
4 BCG Tuberculosis (TB) Vaccine Regional Status and Outlook
  1. 4.1 Global BCG Tuberculosis (TB) Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global BCG Tuberculosis (TB) Vaccine Historic Market Size by Region
  3. 4.2.1 Global BCG Tuberculosis (TB) Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global BCG Tuberculosis (TB) Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global BCG Tuberculosis (TB) Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global BCG Tuberculosis (TB) Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global BCG Tuberculosis (TB) Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global BCG Tuberculosis (TB) Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global BCG Tuberculosis (TB) Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 BCG Tuberculosis (TB) Vaccine by Application
  1. 5.1 BCG Tuberculosis (TB) Vaccine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global BCG Tuberculosis (TB) Vaccine Market Size by Application
  5. 5.2.1 Global BCG Tuberculosis (TB) Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global BCG Tuberculosis (TB) Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global BCG Tuberculosis (TB) Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America BCG Tuberculosis (TB) Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe BCG Tuberculosis (TB) Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America BCG Tuberculosis (TB) Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 China National Biotec
  2. 6.1.1 China National Biotec Company Information
  3. 6.1.2 China National Biotec Business Overview
  4. 6.1.3 China National Biotec BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 China National Biotec BCG Tuberculosis (TB) Vaccine Product Portfolio
  6. 6.1.5 China National Biotec Recent Developments
  7. 6.2 Sanofi Pasteur
  8. 6.2.1 Sanofi Pasteur Company Information
  9. 6.2.2 Sanofi Pasteur Business Overview
  10. 6.2.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Portfolio
  12. 6.2.5 Sanofi Pasteur Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck BCG Tuberculosis (TB) Vaccine Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Serum Institute of India
  20. 6.4.1 Serum Institute of India Company Information
  21. 6.4.2 Serum Institute of India Business Overview
  22. 6.4.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Portfolio
  24. 6.4.5 Serum Institute of India Recent Developments
  25. 6.5 Japan BCG Lab
  26. 6.5.1 Japan BCG Lab Company Information
  27. 6.5.2 Japan BCG Lab Business Overview
  28. 6.5.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Portfolio
  30. 6.5.5 Japan BCG Lab Recent Developments
  31. 6.6 Intervax
  32. 6.6.1 Intervax Company Information
  33. 6.6.2 Intervax Business Overview
  34. 6.6.3 Intervax BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Intervax BCG Tuberculosis (TB) Vaccine Product Portfolio
  36. 6.6.5 Intervax Recent Developments
  37. 6.7 GSBPL
  38. 6.7.1 GSBPL Company Information
  39. 6.7.2 GSBPL Business Overview
  40. 6.7.3 GSBPL BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GSBPL BCG Tuberculosis (TB) Vaccine Product Portfolio
  42. 6.7.5 GSBPL Recent Developments
7 North America by Country
  1. 7.1 North America BCG Tuberculosis (TB) Vaccine Sales by Country
  2. 7.1.1 North America BCG Tuberculosis (TB) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America BCG Tuberculosis (TB) Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America BCG Tuberculosis (TB) Vaccine Market Size by Country
  6. 7.2.1 North America BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America BCG Tuberculosis (TB) Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America BCG Tuberculosis (TB) Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe BCG Tuberculosis (TB) Vaccine Sales by Country
  2. 8.1.1 Europe BCG Tuberculosis (TB) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe BCG Tuberculosis (TB) Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe BCG Tuberculosis (TB) Vaccine Market Size by Country
  6. 8.2.1 Europe BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe BCG Tuberculosis (TB) Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe BCG Tuberculosis (TB) Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America BCG Tuberculosis (TB) Vaccine Sales by Country
  2. 10.1.1 South America BCG Tuberculosis (TB) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America BCG Tuberculosis (TB) Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America BCG Tuberculosis (TB) Vaccine Market Size by Country
  6. 10.2.1 South America BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America BCG Tuberculosis (TB) Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America BCG Tuberculosis (TB) Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 BCG Tuberculosis (TB) Vaccine Value Chain Analysis
  2. 12.1.1 BCG Tuberculosis (TB) Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 BCG Tuberculosis (TB) Vaccine Production Mode & Process
  7. 12.2 BCG Tuberculosis (TB) Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 BCG Tuberculosis (TB) Vaccine Distributors
  10. 12.2.3 BCG Tuberculosis (TB) Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst